Finnish Institute for Health and Welfare: Hepatitis C spreads in Finland primarily through drug use
The Finnish Institute for Health and Welfare (THL) has released new information regarding the situation of hepatitis C infections in Finland. According to the latest report, the majority of infections are still linked to intravenous drug use.
According to THL, hepatitis C is a serious liver disease that spreads through blood. In Finland, infections are concentrated particularly among groups of people who use drugs by injecting. This is a significant public health challenge that authorities are aiming to address through preventive measures.
Experts state that reducing infections requires a diverse range of services. Needle and syringe exchange programs and low-threshold health services, for example, play an important role. These are intended to reduce the spread of infections and provide care to those who need it.
Although the situation is concerning, hepatitis C is now a highly treatable disease. Modern medications effectively cure most patients if the infection is detected early. THL emphasizes that early diagnosis and the initiation of treatment are key to managing the disease.
Work continues in Finland to prevent infections and improve access to treatment. Authorities remind that open discussion and increased awareness are essential means to support those in high-risk groups and improve the health of the entire population.